Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

Stock Information for electroCore Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About electroCore Inc.

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
Millrose Properties Set to Join S&P SmallCap 600
Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.